Metoprolol Succinate Sustained Release 50 mg is a beta-1 selective adrenergic receptor blocker used to treat various cardiovascular conditions. The sustained release formulation ensures a controlled release of the drug over an extended period, allowing for once-daily dosing and improved patient compliance.
Each film-coated sustained-release tablet contains:
Metoprolol Succinate IP equivalent to Metoprolol Tartrate 50 mg
Excipients: q.s.
Tablet Characteristics:
Round or oval, film-coated tablet
Color: Typically white or light pink (may vary by brand)
Engraved or scored (varies by manufacturer)
Supplied in strips or HDPE bottles
Pharmacological Class:
Beta-1 Adrenergic Blocker (Cardioselective Beta-Blocker)
Indications:
Hypertension (high blood pressure)
Angina pectoris (chest pain)
Heart failure (mild to moderate)
Post-myocardial infarction (heart attack)
Arrhythmias
May be used in migraine prophylaxis
Dosage:
As directed by a physician
Usual adult dose: 50 mg once daily, which may be adjusted up to 100–200 mg/day depending on response
Contraindications:
Severe bradycardia
Heart block greater than first degree
Cardiogenic shock
Hypersensitivity to Metoprolol or other beta-blockers
Side Effects:
Fatigue, dizziness, slow heartbeat
Cold extremities
Gastrointestinal discomfort
May mask symptoms of hypoglycemia in diabetic patients
Storage:
Store below 25°C
Protect from moisture and light
Keep out of reach of children
Post Free Ad
www